About Cresilon
Cresilon is a company based in New York (United States) founded in 2010.. Cresilon has raised $113.35 million across 7 funding rounds from investors including Paulson Investment Company. Cresilon offers products and services including VETIGEL and TRAUMAGEL. Cresilon operates in a competitive market with competitors including Adocia, Imbed Biosciences, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others.
- Headquarter New York, United States
-
Sectors
TechnologyHealthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cresilon, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$113.35 M (USD)
in 7 rounds
-
Latest Funding Round
$6.68 M (USD), Series B
Nov 21, 2025
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cresilon
Cresilon offers a comprehensive portfolio of products and services, including VETIGEL and TRAUMAGEL. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Gel that stops bleeding in animals within seconds.
Gel for controlling bleeding in human trauma situations.
Unlock access to complete
Funding Insights of Cresilon
Cresilon has successfully raised a total of $113.35M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $6.68 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $6.7M
-
First Round
First Round
(01 Nov 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Series B - Cresilon | Valuation |
investors |
|
| Apr, 2024 | Amount | Series B - Cresilon | Valuation |
investors |
|
| Aug, 2023 | Amount | Series A - Cresilon | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cresilon
Cresilon has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Paulson Investment Company. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment banking services are provided for small to mid-cap markets.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cresilon
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cresilon
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cresilon Comparisons
Competitors of Cresilon
Cresilon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Imbed Biosciences, Kane Biotech, Alafair Biosciences and Lohmann & Rauscher, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Dressing materials and medical devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cresilon
Frequently Asked Questions about Cresilon
When was Cresilon founded?
Cresilon was founded in 2010 and raised its 1st funding round 6 years after it was founded.
Where is Cresilon located?
Cresilon is headquartered in New York, United States. It is registered at New York, New York, United States.
Is Cresilon a funded company?
Cresilon is a funded company, having raised a total of $113.35M across 7 funding rounds to date. The company's 1st funding round was a Series A of $17.24M, raised on Nov 01, 2016.
What does Cresilon do?
Cresilon was founded in 2010 and is based in New York, United States. Operations focus on the medical device sector, where hemostatic gels and devices are developed to control bleeding. VETIGEL, a prescription gel kit, is provided for moderate to severe bleeds in animals only. TRAUMAGEL serves as a temporary device for external traumatic bleeding unsuitable for tourniquets in humans.
Who are the top competitors of Cresilon?
Cresilon's top competitors include Imbed Biosciences, Adocia and Kane Biotech.
What products or services does Cresilon offer?
Cresilon offers VETIGEL and TRAUMAGEL.
Who are Cresilon's investors?
Cresilon has 1 investor. Key investors include Paulson Investment Company.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.